Legal 500
  • Rankings

    • Jurisdictions

    • Submissions

    • Research+

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

  • Rankings

    • Jurisdictions

    • Submissions

    • Research+

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Contact Us
  • Article

    CMS Posts January 2015 Update To Medicare Part B Drug Pricing Files

    CMS has posted the January 2015 update to the Medicare average sales price (ASP) drug pricing files, which contain the payment amounts that CMS will use to pay for Part B covered drugs for the first quarter of 2015.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS Posts Revised Gapfill Payments For New Molecular Pathology Codes; Reconsideration Requests Due Oct. 30, 2013

    CMS has posted revised Medicare gapfill prices, including the 2014 National Limit Amount (NLA), for new molecular pathology codes under the Medicare Clinical Laboratory Fee Schedule (CLFS).
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS Posts Update To 2016 MPFS Rates

    CMS has posted corrections to the 2016 Medicare physician fee schedule payment files. Among other things, CMS has revised the conversion factor, reducing it slightly from $35.8279 to $35.8043.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS Proposes Changes To Payment Error Rate Measurement (PERM) & Medicaid Eligibility Quality Control (MEQC) Programs

    CMS has issued a proposed rule to make changes to the PERM and MEQC programs to align with changes to state adjudication of Medicaid and Children's Health Insurance Program eligibility under the Affordable Care Act.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS Proposes Changes To Stabilize ACA Health Insurance Markets

    At the same time Republican Congressional leaders are attempting to develop legislation to repeal and replace the ACA, CMS has published a proposed rule that is intended to help stabilize...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS Proposes FY 2015 Update To Inpatient Psychiatric Facility PPS

    CMS proposed a rule to update prospective payment rates for Medicare inpatient hospital services provided by inpatient psychiatric facilities for FY 2015.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS Proposes Reforms To PACE Program

    CMS is proposing numerous changes to the regulations governing the PACE program, which is a Medicare/Medicaid managed care service delivery model designed to enable nursing home-eligible elderly individuals to remain in the community.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS Proposes Removing 10 Medicare National Coverage Policies

    CMS has proposed removing 10 longstanding Medicare national coverage determinations under an expedited process outlined in an August 7, 2013 Federal Register notice.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS Releases 2016 Medicare Advantage/Part D Drug Plan Rates and Policies

    CMS has released the 2016 Medicare Advantage (MA) and Part D Rate Announcement and Call Letter.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS Releases April 2015 Medicare Part B Drug ASP Update

    CMS has posted its April 2015 update to the Medicare average sales price (ASP) drug pricing files, which contain the payment amounts CMS will use to pay for Part B covered drugs for the second quarter of 2015.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS Releases Fourth Quarter 2013 Drug ASP Files

    CMS has released the October 2013 Medicare average sales price file update, which reflects payment amounts be used to pay for Part B drugs for the fourth quarter of 2013.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS Releases Hospital Outpatient Payment Rule

    The Centers for Medicare & Medicaid Services recently released its proposed rule implementing changes to the Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System for calendar year 2014.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Drinker Biddle & Reath LLP
    Drinker Biddle & Reath LLP
  • Article

    CMS Releases Preliminary 2019 Medicare Clinical Lab Payment Determinations

    CMS Releases Preliminary 2019 Medicare Clinical Lab Payment Determinations.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS Rolls Out New Form for Disclosing Potential Stark Act Violations

    CMS has released a new Self-Referral Disclosure Protocol (SRDP) Form for disclosing actual or potential violations of the physician self-referral law (known as the "Stark Act") under CMS's existing self-disclosure process.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS Seeks Innovative Models On Beneficiary Engagement And Behavioral Insights

    CMS is seeking input on potential initiatives to test innovative models that increase the engagement of Medicare, Medicaid, and/or Children’s Health Insurance Program (CHIP) beneficiaries in their health and health care.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS To Expand Nursing Home MDS Focused Surveys

    In mid-2014, state survey agencies and CMS piloted a short-term focused survey in five states to assess nursing home Minimum Data Set, Version 3.0 (MDS 3.0) coding practices and its relationship to resident care.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS Updates Inpatient Hospital "Two Midnight" Review Education/Enforcement Strategy

    CMS recently provided an update on its education and enforcement strategies related to its "Two Midnight" policy, which addresses when surgical procedures, diagnostic tests and other treatments ..
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS Updates Medicare Part B Drug Pricing Files

    The files contain the payment amounts that CMS will use to pay for Part B covered drugs for the fourth quarter of 2014.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    Final Stark Law Regulations Published By CMS

    As previously discussed here and on our Health Industry Washington Watch blog here the Centers for Medicare & Medicaid Services (CMS) has released final regulations under the physician self-referral law known as the Stark Law.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    OIG Recommends Expansion Of CMS's Medicare Part B Drug Pricing Substitution Policy

    The OIG has issued a report which assesses CMS’s use of its authority to lower reimbursement for Medicare Part B drugs.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith

Showing 141–160 of 15663 results

PreviousNext